Form 10-Q Karyopharm Therapeutics For: Sep 30

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 10/26/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD

6. WCN
7. SPOT
8. SPY
9. FIX
10. NDAQ

Karyopharm Therapeutics (KPTI) Files $200M Mixed Securities Shelf

November 8, 2016 8:56 AM EST

Karyopharm Therapeutics (Nasdaq: KPTI) filed a registration with the U.S. SEC to sell up to $200 million of mixed securities.

... More

November 7, 2016 4:28 PM EST

Karyopharm Therapeutics (NASDAQ: KPTI) reported Q3 EPS of ($0.69), $0.12 better than the analyst estimate of ($0.81).

For earnings history and earnings-related data on Karyopharm Therapeutics (KPTI) click here.

... More